VisionPoint Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

VisionPoint Advisory Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65M	Sell	5,277 -2,144	-29%	-$1.03M	0.43%	58
2026 Q1	$3.65M	Sell	7,421 -260	-3%	-$141K	0.69%	29
2025 Q4	$4.45M	Sell	7,681 -674	-8%	-$381K	0.87%	25
2025 Q3	$4.05M	Buy	8,355 +3,969	+90%	+$1.85M	0.81%	27
2025 Q2	$1.78M	Buy	4,386 +938	+27%	+$392K	0.39%	71
2025 Q1	$1.72M	Buy	3,448 +2,483	+257%	+$1.34M	0.59%	50
2024 Q4	$504K	Buy	965 +100	+12%	+$55K	0.17%	109
2024 Q3	$535K	Buy	865 +51	+6%	+$30.2K	0.18%	109
2024 Q2	$450K	Buy	814 +180	+28%	+$103K	0.16%	113
2024 Q1	$368K	Buy	634 +106	+20%	+$59.5K	0.13%	137
2023 Q4	$280K	Buy	528 +55	+12%	+$26.6K	0.1%	134
2023 Q3	$239K	Hold	473	–	–	0.1%	133
2023 Q2	$247K	Buy	473 +43	+10%	+$23.2K	0.1%	122
2023 Q1	$235K	Sell	430 -38	-8%	-$21.4K	0.1%	130
2022 Q4	$269K	Sell	468 -128	-21%	-$67.8K	0.11%	112
2022 Q3	$302K	Buy	596 +39	+7%	+$21.8K	0.15%	71
2022 Q2	$330K	Buy	+557	New	+$307K	0.13%	76

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

VisionPoint Advisory Group's TMO Position: Q2 2026 in Review

VisionPoint Advisory Group reduced its Thermo Fisher Scientific (TMO) stake by 29% in Q2 2026, selling an estimated $1.03M and leaving 5,277 shares worth $2.65M. The position accounts for 0.43% of the portfolio, ranked #58.

VisionPoint Advisory Group first reported a position in TMO in Q2 2022 and has held it in 17 quarters since. The position peaked at $4.45M in Q4 2025. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

VisionPoint Advisory Group held 5,277 shares of Thermo Fisher Scientific worth $2.65M as of Q2 2026.
VisionPoint Advisory Group sold 2,144 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.03M.
Thermo Fisher Scientific made up 0.43% of VisionPoint Advisory Group's portfolio in Q2 2026, its #58 holding.
VisionPoint Advisory Group first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 17 quarters since.
VisionPoint Advisory Group's Thermo Fisher Scientific position peaked at $4.45M in Q4 2025.
429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.